Streetbeat News

Stock Prices

DOCU

DocuSign shares are experiencing an upward trend following the announcement that the company will be included in the S&P MidCap 400 index.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:51 am

PEP

PepsiCo reported mixed Q3 results with a slight revenue decline and lowered its 2024 revenue guidance. Despite challenges, the company maintained profitability through cost controls. PepsiCo expects a low single-digit increase in organic revenue and at least 8% EPS growth for 2024.

Portfolio Pulse from Akanksha Bakshi

October 08, 2024 | 11:28 am

PEP

QQQ

SPY

US stocks are set to rebound as bond yields dip and oil prices slide. Fed Governor Adriana Kugler's dovish comments on potential rate cuts and a focus on employment are boosting sentiment. However, PepsiCo's earnings miss and reduced growth outlook weigh on the market. ETFs like SPY and QQQ are seeing premarket gains.

Portfolio Pulse from Shanthi Rexaline

October 08, 2024 | 11:12 am

APD

CARR

HON

Honeywell International plans to spin off its Advanced Materials unit into a separate publicly traded company, aiming to simplify its structure and boost flexibility. The spin-off, valued over $10 billion, is part of Honeywell's strategy to focus on automation, aviation, and energy transition. The move aligns with a trend among industrial conglomerates to streamline operations. Honeywell has been active in acquisitions and recently increased its dividend.

Portfolio Pulse from Vandana Singh

October 08, 2024 | 11:07 am

AVTX

Avalo Therapeutics has initiated the Phase 2 LOTUS trial for AVTX-009, targeting Hidradenitis Suppurativa. The trial will involve approximately 180 adults, with topline data expected in 2026.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:07 am

HON

Honeywell shares rise as the company announces plans to spin off its Advanced Materials business into a separate publicly traded entity.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 11:04 am

CRK

RES

Two energy stocks, RPC Inc (RES) and Comstock Resources Inc (CRK), are currently overbought according to their RSI values, suggesting potential caution for investors. RES has gained 12% in the past five days, while CRK has risen 30% over the past month.

Portfolio Pulse from Avi Kapoor

October 08, 2024 | 10:55 am

SAGE

Sage Therapeutics has halted the development of its Alzheimer's drug, dalzanemdor, after unsatisfactory results from the Phase 2 LIGHTWAVE Study, leading to a decline in its stock price.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:54 am

MRK

Merck's Phase 3 KEYNOTE-689 trial of Keytruda for treating head and neck cancer met its primary endpoint of event-free survival and showed significant improvement in major pathological response. The safety profile was consistent with previous studies.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 10:48 am

DOCU

MDU

DocuSign shares rose 5.7% in pre-market trading as it is set to replace MDU Resources in the S&P MidCap 400. Other notable pre-market movers include Nature’s Miracle, Ontrak, and Nuburu, with significant gains, while SOBR Safe and Cemtrex saw notable declines.

Portfolio Pulse from Avi Kapoor

October 08, 2024 | 10:36 am